These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22028136)

  • 1. [α2-Adrenergic agonists, and drugs for ADHD].
    Clement HW; Schulz E
    Pharm Unserer Zeit; 2011 Nov; 40(6):503-9. PubMed ID: 22028136
    [No Abstract]   [Full Text] [Related]  

  • 2. Guanfacine extended-release (intuniv) for ADHD.
    Med Lett Drugs Ther; 2010 Oct; 52(1349):82-3. PubMed ID: 21045757
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder.
    Sallee FR
    Postgrad Med; 2010 Sep; 122(5):78-87. PubMed ID: 20861591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder.
    Kaplan G; Newcorn JH
    Pediatr Clin North Am; 2011 Feb; 58(1):99-120, xi. PubMed ID: 21281851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the rationale and clinical utilization of α2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders.
    Sallee F; Connor DF; Newcorn JH
    J Child Adolesc Psychopharmacol; 2013 Jun; 23(5):308-19. PubMed ID: 23782125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents.
    Rizzo R; Martino D
    Expert Rev Neurother; 2015 Apr; 15(4):347-54. PubMed ID: 25800130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating ADHD in Prison: Focus on Alpha-2 Agonists (Clonidine and Guanfacine).
    Mattes JA
    J Am Acad Psychiatry Law; 2016 Jun; 44(2):151-7. PubMed ID: 27236168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of postsynapse adrenergic α2A receptor improves attention/cognition performance in an animal model of attention deficit hyperactivity disorder.
    Kawaura K; Karasawa J; Chaki S; Hikichi H
    Behav Brain Res; 2014 Aug; 270():349-56. PubMed ID: 24882610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In the pipeline: non-stimulant ADHD meds.
    Glazer WM
    Behav Healthc; 2010 Jan; 30(1):30-1. PubMed ID: 20184258
    [No Abstract]   [Full Text] [Related]  

  • 10. Guanfacine ER for the treatment of adolescent attention-deficit/hyperactivity disorder.
    Bukstein OG; Head J
    Expert Opin Pharmacother; 2012 Oct; 13(15):2207-13. PubMed ID: 22957772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ▼Guanfacine for ADHD in children and adolescents.
    Drug Ther Bull; 2016 May; 54(5):56-60. PubMed ID: 27173784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sapophagia (compulsive soap eating) and attention-deficit/hyperactivity disorder in a child responsive to clonidine.
    Saddichha S; Vibha P; Vishnuvardhan G
    J Clin Psychopharmacol; 2012 Apr; 32(2):291. PubMed ID: 22388159
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychiatry; 2006; 67 Suppl 8():32-8. PubMed ID: 16961428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-2 agonists in the treatment of attention deficit hyperactivity disorder.
    Scahill L; Barloon L; Farkas L
    J Child Adolesc Psychiatr Nurs; 1999; 12(4):168-73. PubMed ID: 10876518
    [No Abstract]   [Full Text] [Related]  

  • 15. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.
    Chappell PB; Riddle MA; Scahill L; Lynch KA; Schultz R; Arnsten A; Leckman JF; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1140-6. PubMed ID: 7559307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD).
    Sallee FR; Eaton K
    Expert Opin Pharmacother; 2010 Oct; 11(15):2549-56. PubMed ID: 20831361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Another extended-release α2-agonist for ADHD.
    Med Lett Drugs Ther; 2011 Feb; 53(1357):10-2. PubMed ID: 21304444
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of the use of clonidine as a sleep aid in the child and adolescent population.
    Nguyen M; Tharani S; Rahmani M; Shapiro M
    Clin Pediatr (Phila); 2014 Mar; 53(3):211-6. PubMed ID: 24027233
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of action of guanfacine: a postsynaptic differential approach to the treatment of attention deficit hyperactivity disorder (adhd).
    Alamo C; López-Muñoz F; Sánchez-García J
    Actas Esp Psiquiatr; 2016 May; 44(3):107-12. PubMed ID: 27254403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs for treatment of ADHD.
    Treat Guidel Med Lett; 2011 May; 9(105):23-8; quiz 2 p following 28. PubMed ID: 21519317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.